Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Protagonist Therapeutics (PTGX) Debt Ratio (2018 - 2023)

Protagonist Therapeutics' Debt Ratio history spans 6 years, with the latest figure at 0.0 for Q2 2023.

  • For Q2 2023, Debt Ratio fell 87.89% year-over-year to 0.0; the TTM value through Jun 2023 reached 0.0, down 87.89%, while the annual FY2022 figure was 0.0, 89.24% down from the prior year.
  • Debt Ratio for Q2 2023 was 0.0 at Protagonist Therapeutics, down from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.03 in Q2 2021 and bottomed at 0.0 in Q2 2023.
  • The 5-year median for Debt Ratio is 0.0 (2019), against an average of 0.01.
  • The largest annual shift saw Debt Ratio surged 532.36% in 2021 before it crashed 99.09% in 2022.
  • A 5-year view of Debt Ratio shows it stood at 0.01 in 2019, then increased by 3.36% to 0.01 in 2020, then plummeted by 69.29% to 0.0 in 2021, then plummeted by 89.24% to 0.0 in 2022, then plummeted by 88.79% to 0.0 in 2023.
  • Per Business Quant, the three most recent readings for PTGX's Debt Ratio are 0.0 (Q2 2023), 0.0 (Q1 2023), and 0.0 (Q4 2022).